Cancer Construction
Inactive
- Assistance listing
- 93.392
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- 12 $11,930,566 in federal obligations
Program facts
- Assistance types
-
- Project Grant
- Block Grant
- Eligible applicants
-
- Private nonprofit institution/organization (includes institutions of higher education and hospitals)
- U.S. Territories and possessions (includes institutions of higher education and hospitals)
- Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals
- State (includes District of Columbia, public institutions of higher education and hospitals)
- Public nonprofit institution/organization (includes institutions of higher education and hospitals)
- Quasi-public nonprofit institution/organization
- Beneficiaries
-
- Specialized group (e.g. health professionals, students, veterans)
- U.S. Territories
- Local
- Private nonprofit institution/organization
- Public nonprofit institution/organization
- State
- Quasi-public nonprofit organization
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Health and Human Services National Institutes of Health administers the Cancer Construction program (CFDA 93.392) to fund renovation of existing cancer research facilities and construction of new cancer research facilities meeting basic and clinical space requirements, laboratory safety, biohazard containment, and animal care standards; the most recent grant award was disbursed on July 23, 2009.
This program has not awarded new grants for over 17 years. The portfolio reflects 12 total awards spanning 2000 to 2009, with an award cadence of one to two grants per year during the 2003–2009 period. Combined federal dollars obligated total $11.9 million across the entire history. The National Institutes of Health is the sole funding agency under this program.
Awarded grants have funded both facility construction and research projects aligned with cancer prevention and detection science. Recent examples include a $3 million project grant for radiation biology research facility development (awarded September 2003, obligated through August 2005), a $2.143 million project grant for PET detector development infrastructure (awarded July 2009), and $1.77 million in facility renovation support (awarded October 2000). Block grants—which comprised 25 percent of awards—funded smaller research initiatives such as novel antibody development and cancer metastasis prevention studies, typically in the $190 thousand to $250 thousand range.
The assistance-type mix is predominantly Project Grants (75 percent, nine awards) with a smaller share of Block Grants (25 percent, three awards). Individual awards ranged from $1,581 to $3 million in federal obligation, with most recent awards (2008–2009) in the $150 thousand to $2.1 million band.
No grant opportunities are currently open under this program. The lengthy hiatus in awards and absence of recent solicitation activity suggests this program is inactive or substantially curtailed from its prior funding cycle.
Objective and description
- Objective
To renovate existing cancer research facilities and build new cancer research facilities to meet basic and clinical space requirements, laboratory safety, biohazard containment, and animal care standards in order to support the facility demands of National Cancer Institute (NCI) research programs.
Grant awards
| Award | Recipient | Federal obligations | Awarded |
|---|---|---|---|
| A synthetic triterpenoid in breast cancer chemoprevention | Northeast Ohio Medical University | $154,000 | |
| A scalable, monolithic, DOI, TOF, MR compatible, pet detector | University Of Washington | $2,143,337 | |
| Selective kgfr antagonists for the prevention of cancer metastasis | — | $219,750 | |
| Novel bispecific antibodies | Panorama Research Incorporated | $190,350 | |
| Liposomal disintegrin: novel and effective antitumor agent phase i | Molecular Express, Inc. | $248,564 | |
| Project Grant 1C06CA5869001S | — | $870,000 | |
| Project Grant 1C06CA58690010 | — | $900,000 | |
| Project Grant 1C06RR018954010 | — | $3,000,000 | |
| Project Grant 1C06RR17510010 | — | $1,500,000 | |
| Project Grant N2CM77043A00000 | — | $1,581 |
Latest 10 of 12 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | University Of Washington | $2,143,337 | 18% |
| 2 | ST Jude Children's Research Hospital Inc. | $932,984 | 8% |
| 3 | Molecular Express, Inc. | $248,564 | 2% |
| 4 | Panorama Research Incorporated | $190,350 | 2% |
| 5 | Northeast Ohio Medical University | $154,000 | 1% |
5 of 6 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2012 | $790,456 |
| FY2010 | $6,661,229 |
| FY2009 | $6,687,798 |
| FY2008 | $5,837,890 |
| FY2007 | $1,220,195 |
| FY2006 | $1,770,000 |
| FY2003 | $3,000,000 |
| FY2002 | $1,501,581 |
| FY2001 | $1,770,000 |
Quick answers
What is Assistance Listing 93.392?
Assistance Listing 93.392 is Cancer Construction, a federal grant program run by National Institutes of Health (Department of Health and Human Services). It is inactive.
What is the CFDA number for Cancer Construction?
Its CFDA number is 93.392: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.392 awarded?
12 grant awards under 93.392 have obligated $11,930,566 in federal funds to 6 recipients.
Who receives the most funding from 93.392?
The recipients obligated the most under Cancer Construction are University Of Washington ($2,143,337), ST Jude Children's Research Hospital Inc. ($932,984) and Molecular Express, Inc. ($248,564).
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program